Serum antibodies in epilepsy and seizure-associated disorders

  • K. McKnight
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • Y. Jiang
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • Y. Hart
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • A. Cavey
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • S. Wroe
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • M. Blank
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • Y. Shoenfeld
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • A. Vincent
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • J. Palace
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...
  • B. Lang
    From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty...

書誌事項

公開日
2005-12-13
DOI
  • 10.1212/01.wnl.0000187129.66353.13
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

収録刊行物

  • Neurology

    Neurology 65 (11), 1730-1736, 2005-12-13

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (7)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ